Nationwide Children’s Spinoff Tackles Antibiotic Resistance
January 20, 2025
Clarametyx Biosciences, a spinoff from Nationwide Children’s Hospital, is developing a groundbreaking vaccine to combat antibiotic resistance. If successful, this innovation could mark one of the most significant advancements in modern medicine, addressing a critical global health challenge.